Publications in the NUM

K G, S F, D K, F S, T G, D W. The Status of Data Management Practices Across German Medical Data Integration Centers: Mixed Methods Study.. Journal of medical Internet research. 2023 Nov.;      [DOI] 

Lücke J, Nawrocki M, Schnell J, Meins N, Heinrich F, Zhang T, Bertram F, Sabihi M, Böttcher M, Blankenburg T, Pfaff M, Notz S, Kempski J, Reeh M, Wolter S, Mann O, Izbicki JR, Lütgehetmann M, Duprée A, Giannou AD, Ondruschka B, Huber S. TNFα aggravates detrimental effects of SARS-CoV-2 infection in the liver. Frontiers in Immunology. 2023; 141151937.      [DOI] 

P T, L L, C K, D B, A L, M B, HA K. Unsupervised domain adaptation for the detection of cardiomegaly in cross-domain chest X-ray images.. Frontiers in artificial intelligence. 2023;      [DOI] 

Woo MS, Shafiq M, Fitzek A, Dottermusch M, Mohammadi B, Mayer C, Bal LC, Raich L, Matschke J, Krasemann S, Pfefferle S, Brehm TT, Lütgehetmann M, Schädler J, Wiesch J, Ondruschka B, Friese MA, Glatzel M. Vagus nerve inflammation contributes to dysautonomia in COVID-19. Acta Neuropathologica. 2023 Sep.; 146(3):387—394.      [DOI]      [File] 

A S, M T, C B, A W, J B. Validation of clinical-radiological scores for prognosis of mortality in acute pulmonary embolism.. Respiratory research. 2023 Aug.;      [DOI] 

A S, M T, H K, M H, J O, E C, M C, M D, İ K, Ç O, Ö Y, E H, E I, H Ö, H E, O C, H S, KA G, M P, A W. Visceral to subcutaneous fat ratio predicts short-term mortality in patients with Covid 19. A multicenter study.. The British journal of radiology. 2023 Mar.;      [DOI] 

Mieling R, Neidhardt M, Latus S, Stapper C, Gerlach S, Kniep I, Heinemann A, Ondruschka B, Schlaefer A. Collaborative Robotic Biopsy with Trajectory Guidance and Needle Tip Force Feedback. In: 2023 IEEE International Conference on Robotics and Automation (ICRA). 2023 May. p. 6893—6900.      [DOI] 

Triefenbach L, Otto R, Bienzeisler J, Kombeiz A, Ehrentreich S, Röhrig R, Majeed RW. Establishing a data quality baseline in the AKTIN Emergency Department Data Registry – A secondary use perspective. Stud Health Technol Inform.. 2022 May 25; 294(25):209-213.      [DOI]  [Pubmed] 

Wang Z, Cryar A, Lemke O, Tober-Lau P, Ludwig D, Helbig E, Hippenstiel S, Sander L, Blake D, Lane C, Stahl D. A multiplex protein panel assay for severity prediction and outcome prognosis in patients with COVID-19: An observational multi-cohort study. EClinicalMedicine. 2022; 49101495.      [DOI] 

Demichev V, et al . A proteomic survival predictor for COVID-19 patients in intensive care. PLOS Digital Health. 2022; 1e0000007.      [DOI] 

Würstle S, Erber J, Hanselmann M, Stahl D. A telemedicine-guided self-collection approach for PCR-based SARS-CoV-2 testing: Comparative study. JMIR Formative Research. 2022; 6(1):      [DOI]      [File] 

Wygrecka M, Birnhuber A, Seeliger B, Michalick L, Pak O, Schultz A, Schramm F, Zacharias M, Gorkiewicz G, David S, Welte T, Schmidt J, Weissmann N, Schermuly R, Barreto G, Schaefer L, Markart P, Brack M, Hippenstiel S, Kurth F, Sander L, Witzenrath M, Kuebler W, Kwapiszewska G, Preissner K. Altered fibrin clot structure and dysregulated fibrinolysis contribute to thrombosis risk in severe COVID-19. Blood Adv. 2022; 6(3):1074—1087.      [DOI] 

Gagiannis D, Umathum VG, Bloch W, Rother C, Stahl M, Witte HM, Djudjaj S, Boor P, Steinestel K. Antemortem vs Postmortem Histopathologic and Ultrastructural Findings in Paired Transbronchial Biopsy Specimens and Lung Autopsy Samples From Three Patients With Confirmed SARS-CoV-2. American Journal of Clinical Pathology. 2022 Jan.; 157(1):54—63.      [DOI]      [File] 

Krasemann S, Dittmayer C, Stillfried S, Meinhardt J, Heinrich F, Hartmann K, Pfefferle S, Thies E, Manitius R, Aschman TAD, Radke J, Osterloh A, Schmid S, Buhl EM, Ihlow J, Dubois F, Arnhold V, Elezkurtaj S, Horst D, Hocke A, Timm S, Bachmann S, Corman V, Goebel H, Matschke J, Stanelle-Bertram S, Gabriel G, Seilhean D, Ondruschka B, Ochs M, Stenzel W, Heppner FL, Boor P, Radbruch H, Laue M, Glatzel M. Assessing and improving the validity of COVID-19 autopsy studies - A multicentre approach to establish essential standards for immunohistochemical and ultrastructural analyses. EBioMedicine. 2022 Sep.; 83104193.      [DOI] 

P F, F F, A J, M R, M W, P P, J K, H C, S L, D M, R S, T P. Assessment of COVID-19 lung involvement on computed tomography by deep-learning-, threshold-, and human reader-based approaches-an international, multi-center comparative study.. Quantitative imaging in medicine and surgery. 2022 Nov.;      [DOI] 

Buhr L, Schicktanz S, Nordmeyer E. Attitudes Toward Mobile Apps for Pandemic Research Among Smartphone Users in Germany: National Survey. JMIR Mhealth Uhealth. 2022; 10(1):e31857.      [DOI] 

Schulz SR, et al . Augmented Neutralization of SARS-CoV-2 Omicron Variant by Boost Vaccination and Monoclonal Antibodies. European journal of immunology. 2022;      [DOI] 

Schmid B, Griesel M, Fischer A, Romero CS, Metzendorf M, Weibel S, Fichtner F. Awake Prone Positioning, High-Flow Nasal Oxygen and Non-Invasive Ventilation as Non-Invasive Respiratory Strategies in COVID-19 Acute Respiratory Failure: A Systematic Review and Meta-Analysis. J Clin Med. 2022; 11(2):391.      [DOI] 

Demleitner AF, Wolff A, Erber J, et al . Best practice approaches to outpatient management of people living with Parkinson's disease during the COVID-19 pandemic. J Neural Transm (Vienna). 2022; 129(11):1377-1385.      [DOI] 

Lingscheid T, Lippert L, Hillus D, Kruis T, Thibeault C, Helbig E, Tober-Lau P, Pfäfflin F, Müller-Redetzky H, Witzenrath M, Zoller T, Uhrig A, Opitz B, Suttorp N, Kramer T, Sander L, Stegemann M, Kurth F. Characterization of antimicrobial use and co-infections among hospitalized patients with COVID-19: a prospective observational cohort study. Infection. 2022; 50(6):1441—1452.      [DOI] 

Walker A, Houwaart T, Finzer P, Ehlkes L, Tyshaieva A, Damagnez M, Strelow D, Duplessis A, Nicolai J, Wienemann T, Tamayo T, Kohns Vasconcelos M, Hülse L, Hoffmann K, Lübke N, Hauka S, Däumer MP, Thielen A, Kolbe-Busch S, Göbels K, Zotz R, Pfeffer K, Timm J, Dilthey AT. Characterization of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Clusters Based on Integrated Genomic Surveillance, Outbreak Analysis and Contact Tracing in an Urban Setting. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2022; 74(6):1039—1046.      [DOI] 

Dulovic A, et al . Comparative Magnitude and Persistence of Humoral SARS-CoV-2 Vaccination Responses in the Adult Population in Germany. Frontiers in Immunology. 2022; 13828053.      [DOI] 

Georg P, Astaburuaga-García R, Bonaguro L, Brumhard S, Michalick L, Lippert ea. Complement activation induces excessive T cell cytotoxicity in severe COVID-19. Cell. 2022; 185493—512.e425.

Brandner J, Boor P, Borcherding L, et al . Contamination of personal protective equipment during COVID-19 autopsies. Virchows Arch. 2022; 1-10.      [DOI] 

Mardiko AA, Heinemann S, Bludau A, Kaba HEJ, Leha A, Maltzahn N, Mutters NT, Leistner R, Mattner F, Scheithauer S. COVID-19 vaccination strategy for hospital staff in Germany: a cross-sectional study in March-April 2021. The Journal of hospital infection. 2022; 12687—92.      [DOI] 

Scheithauer S, Bludau A, Heinemann S, Anton M, Knolle P. COVID-19-Impfstrategien für Beschäftigte deutscher Kliniken: Ergebnisse einer Befragung von Leitungen der (Krankenhaus\hbox-)Hygiene im Rahmen des B-FAST-Projektes. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz. 2022; 65(12):1299—1306.      [DOI] 

Radbruch L, Bausewein C. Covid-19: Was die Palliativmedizin leisten kann. Rheinisches Ärzteblatt. 2022; (6):

Tober-Lau P, et al . Cross-Variant Neutralizing Serum Activity after SARS-CoV-2 Breakthrough Infections. Emerging infectious diseases. 2022; 28      [DOI] 

Meyer-Arndt L, et al . Cutting Edge: Serum but Not Mucosal Antibody Responses Are Associated with Pre-Existing SARS-CoV-2 Spike Cross-Reactive CD4+ T Cells following BNT162b2 Vaccination in the Elderly. Journal of immunology. 2022; 2081001–1005.      [DOI] 

Chen H, Maul‐Pavicic A, Holzer M, et al . Detection and functional resolution of soluble immune complexes by an FcγR reporter cell panel. EMBO Mol Med. 2022; 14(1):      [DOI]      [File] 

Chen H, et al . Detection and functional resolution of soluble immune complexes by an FcγR reporter cell panel. EMBO Mol Med. 2022; 14e14182.      [DOI] 

H A, S E, F M, F S, H C, LH V, E V, A DO, D D, MFH B, BH A, PB S, T P, U H, A M, J N. Diagnostic Accuracy and Reliability of Noncontrast Computed Tomography Markers for Acute Hematoma Expansion among Radiologists.. Tomography (Ann Arbor, Mich.). 2022 Dec.;      [DOI] 

Tauchert M, Bernemann I, Kühn-Steven A, Kopfnagel V, Kunze S, Illig T, Anton G. Digital knowledge management within the NAPKON study. Abstract. 11. Nationales Biobanken Symposium. 2022. Not available. 2022;

C G, K G, M F, A B, A D, R F, IJ K, A M. Distance-based detection of out-of-distribution silent failures for Covid-19 lung lesion segmentation.. Medical image analysis. 2022 Nov.;      [DOI] 

Vanshylla K, et al . Durability of omicron-neutralising serum activity after mRNA booster immunisation in older adults. The Lancet Infectious Diseases. 2022; 22445–446.      [DOI] 

Heinrich F, Romich C, Zimmermann T, Kniep I, Fitzek A, Steurer S, Glatzel M, Nörz D, Günther T, Czech-Sioli M, Fischer N, Grundhoff A, Lütgehetmann M, Ondruschka B. Dying of VOC-202012/01 — multimodal investigations in a death case of the SARS-CoV-2 variant. International Journal of Legal Medicine. 2022 Jan.; 136(1):193—202.      [DOI]      [File] 

Koerber N, Priller A, Yazici S, et al . Dynamics of spike-and nucleocapsid specific immunity during long-term follow-up and vaccination of SARS-CoV-2 convalescents. Nat Commun. 2022; 13(1):      [DOI] 

et al . Early and Rapid Identification of COVID-19 Patients with Neutralizing Type I Interferon Auto-antibodies. Journal of Clinical Immunology. 2022;      [DOI] 

Meyer T, Stubbemann P, Thibeault C, Staudacher O, Niemeyer D, Jansen J, Mühlemann B, Doehn J, Tabeling C, Nusshag C, Hirzel C, Sanchez DS, Nieters A, Lother A, Duerschmied D, Schallner N, Lieberum JN, August D, Rieg S, Falcone V, Hengel H, Kölsch U, Unterwalder N, Hübner R, Jones TC, Suttorp N, Drosten C, Warnatz K, Spinetti T, Schefold JC, Dörner T, Sander LE, Corman VM, Merle U, Group P, Kurth F, Bernuth H, Meisel C, Goffinet C. Early and rapid identification of COVID-19 patients with neutralizing type I interferon auto-antibodies. J. Clin. Immunol.. 2022 Aug.; 42(6):1111—1129.      [DOI]  [Pubmed] 

Pietzner M, Chua RL, Wheeler E, Jechow K, Radbruch H, Trump ea. ELF5 is a respiratory epithelial cell-specific risk gene for severe COVID-19. medRxiv. 2022;      [DOI] 

Hopff S, Tilch K, Kraus M, Lorenz-Depiereux L, Anton G, Appel K, Bahmer T, Bartschke A, Bellinghausen C, Bernemann I, Stahl D. Ethical and coordinative challenges in setting up a national cohort study exemplified by the German National Pandemic Cohort Network (NAPKON). Abstract ECCMID 2022. 2022;

Antoniou K, Vasarmidi E, Russell A, Crestani B, Delcroix M, Dinh-Xuan A, Poletti V, Sverzellati N, Vitacca M, Witzenrath M, Tonia T, Spanevello A. European Respiratory Society statement on long COVID follow-up. Eur Respir J. 2022; 60(2):2102174.      [DOI] 

Krüger L, Klein J, Tobian F, Stahl D. Evaluation of accuracy, exclusivity, limit-of-detection and ease-of-use of LumiraDx™: An antigen-detecting point-of-care device for SARS-CoV-2. Infection. 2022; 50      [DOI]      [File] 

Hoffmann M, et al . Evidence for an ACE2-Independent Entry Pathway That Can Protect from Neutralization by an Antibody Used for COVID-19 Therapy. mBio. 2022;      [DOI] 

Hartung TJ, Neumann C, Bahmer T, Chaplinskaya-Sobol I, Endres M, Geritz J, Haeusler KG, Heuschmann PU, Hildesheim H, Hinz A, Hopff S, Horn A, Krawczak M, Krist L, Kudelka J, Lieb W, Maetzler C, Mehnert-Theuerkauf A, Montellano FA, Morbach C, Schmidt S, Schreiber S, Steigerwald F, Störk S, Maetzler W, Finke C. Fatigue and cognitive impairment after COVID-19: A prospective multicentre study. EClinicalMedicine. 2022 Nov.; 53(101651):101651.      [DOI]  [Pubmed] 

Woon S, Sheppard M, et al . First Identified Case of Fatal Fulminant Necrotizing Eosinophilic Myocarditis Following the Initial Dose of the Pfizer-BioNTech mRNA COVID-19 Vaccine (BNT162b2, Comirnaty): an Extremely Rare Idiosyncratic Hypersensitivity Reaction. J Clin Immunol. 2022;      [DOI] 

Von Stillfried S, Bülow R, Röhrig R, Boor P, Collaborators D. First report from the German COVID-19 autopsy registry. The Lancet Regional Health - Europe. 2022; 100330.      [DOI] 

Stillfried S, Bülow RD, Röhrig R, Boor P, COVID-19 Autopsies (DeRegCOVID) DC. First report from the German COVID-19 autopsy registry. The Lancet Regional Health. Europe. 2022 Apr.; 15100330.      [DOI] 

Steinbeis F, Knape P, Mittermaier M, Helbig E, Tober-Lau P, Thibeault C, Lippert L, Xiang W, Müller-Plathe M, Steinbrecher S, Stahl D. Functional limitations 12 months after SARS-CoV-2 infection correlate with initial disease severity: An observational study of cardiopulmonary exercise capacity testing in COVID-19 convalescents. Respir Med. 2022; 202106968.      [DOI] 

Rosenau L, Majeed RW, Ingenerf J, Kiel A, Kroll B, Köhler T, Prokosch H, Gruendner J. Generation of a Fast Healthcare Interoperability Resources (FHIR)-based Ontology for federated Feasibility Queries in the context of COVID-19: An automated approach. JMIR Med Inform. 2022 Apr.; 10(4):e35789.      [DOI]